Vera Therapeutics, Inc. (VERA)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$533.0M
Stockholders' Equity
$407.8M
Cash & Equivalents
$48.9M
Long-Term Debt
$75.2M

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, Vera Therapeutics, Inc. reported net income of -$109.5M and total assets of $533.0M. Every figure below is taken directly from Vera Therapeutics, Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025—-$299.6M
FY2024—-$152.1M
FY2023—-$96.0M
FY2022—-$89.1M
FY2021—-$32.6M
FY2020—-$53.4M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KSep 15, 2026on EDGAR ↗
8-KAug 10, 2026on EDGAR ↗
10-QAug 10, 2026on EDGAR ↗
8-KJul 9, 2026on EDGAR ↗
8-KJul 7, 2026on EDGAR ↗
8-KJun 2, 2026on EDGAR ↗
8-KMay 26, 2026on EDGAR ↗
8-KMay 7, 2026on EDGAR ↗
10-QMay 7, 2026on EDGAR ↗
DEF 14AApr 9, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$533.0Msource ↗
Stockholders’ Equity$407.8Msource ↗
Cash & Equivalents$48.9Msource ↗
Long-Term Debt$75.2Msource ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue—source ↗
Net Income-$109.5Msource ↗
Operating Income-$112.5Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$60.1Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-1.52source ↗
EPS (basic)$-1.52source ↗
Shares Outstanding72.1Msource ↗
Cash from Operations-$100.3Msource ↗
Cash from Financing$1.9Msource ↗
Cash from Investing$32.9Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
10
Net shares
-120.3K

Restatement history

Point-in-time

No material restatements detected across 138 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches VERA’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Get a free API key →See plans

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/VERA

MCP tool: get_sec_fundamentals ticker=VERA

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/VERA/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=VERA as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/VERA/history

MCP tool: get_fundamentals_history ticker=VERA

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/financial-health/VERA

MCP tool: get_financial_health ticker=VERA

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.